SCHEMBL2369947

SCHEMBL2369947

I[C](I)c1ccccc1I

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
PTPN2 P17706 2/20 0.38
PTPN1 P18031 2/20 0.38
PTPRF P10586 1/20 0.38
ALDH1A1 P00352 2/20 0.35
ALOX15 P16050 1/20 0.35
PARP1 P09874 1/20 0.33
TAAR1 Q96RJ0 1/20 0.32
IDO1 P14902 2/20 0.31
TP53 P04637 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
TSHR P16473 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
MGLL Q99685 2/20 0.30
FAAH O00519 1/20 0.30
RXFP1 Q9HBX9 1/20 0.30
SIGMAR1 Q99720 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1298701 0.80 MEN1 (0.54) MEN1KMT2ATDP1PTPN2PTPN1
SCHEMBL4088432 0.79 MEN1 (0.46) MEN1KMT2ATDP1PTPN2PTPN1
SCHEMBL3839465 0.78 KMT2A (0.52) MEN1KMT2ATDP1PTPN2PTPN1
SCHEMBL22624389 0.78 MEN1 (0.42) MEN1KMT2ATDP1PTPN2PTPN1
SCHEMBL12648858 0.78 MEN1 (0.52) MEN1KMT2ATDP1PTPN2PTPN1
SCHEMBL6893214 0.76 MEN1 (0.41) MEN1KMT2ATDP1PTPN2PTPN1
SCHEMBL18242463 0.74 MEN1 (0.43) MEN1KMT2ATDP1PTPN2PTPN1
SCHEMBL2165280 0.72 MEN1 (0.52) MEN1KMT2ATDP1PTPN2PTPN1
SCHEMBL30516691 0.72 ALDH1A1 (0.65) MEN1KMT2ATDP1PTPN2PTPN1
SCHEMBL13745451 0.72 MEN1 (0.47) MEN1KMT2ATDP1PTPN2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2968618-A2 IMAGEABLE EMBOLIC MICROSPHERE Dreher, Matthew R. (US) 2016-01-20 EP claimed
WO-2014152488-A2 IMAGEABLE EMBOLIC MICROSPHERE DREHER MATTHEW R (US) 2014-09-25 WO claimed
CN-115137870-B Emulsion comprising particles 生物相容性英国公司 2024-05-10 CN disclosed
US-20230285601-A1 NON DEGRADABLE RADIO-OPAQUE EMBOLISATION MICROSPHERE GUERBET (FR) 2023-09-14 US disclosed
US-11672876-B2 Imageable embolic microsphere BIOCOMPATIBLES UK LIMITED (GB) 2023-06-13 US disclosed
CN-115137870-A Emulsions comprising particles 生物相容性英国公司 2022-10-04 CN disclosed
CN-114805644-B Nontransmissive polymer and preparation method and application thereof 苏州美创医疗科技有限公司 2022-09-16 CN disclosed
CN-114805644-A Nontransmissive polymer and preparation method and application thereof 苏州美创医疗科技有限公司 2022-07-29 CN disclosed
US-11383008-B2 Surface-modified polymeric substrates grafted with a properties-imparting compound using clip chemistry CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2022-07-12 US disclosed
CN-108883189-B Emulsion comprising particles 生物相容性英国公司 2022-06-21 CN disclosed
EP-3131897-B1 FACTOR IXA INHIBITORS MERCK SHARP & DOHME (US) 2022-06-15 EP disclosed
EP-2968618-A2 IMAGEABLE EMBOLIC MICROSPHERE Dreher, Matthew R. (US) 2016-01-20 EP disclosed
US-20150335779-A1 Method of Embolization using a Radiopaque, Non-Biodegradable, Water-Insoluble Iodinated Benzyl Ether of PolyI(Vinyl Alcohol) ANTIA THERAPEUTICS S.A. (CH) 2015-11-26 US disclosed
WO-2015160634-A1 FACTOR IXA INHIBITORS MERCK SHARP & DOHME CORP. (US) 2015-10-22 WO disclosed
WO-2015160636-A1 FACTOR IXA INHIBITORS MERCK SHARP & DOHME CORP. (US) 2015-10-22 WO disclosed
US-9115230-B2 Radiopaque, non-biodegradable, water-insoluble iodinated benzyl ethers of poly(vinyl alcohol), preparation method thereof, injectable embolizing compositions containing thereof and use thereof ANTIA THERAPEUTICS S.A. (CH) 2015-08-25 US disclosed
WO-2014152488-A2 IMAGEABLE EMBOLIC MICROSPHERE DREHER MATTHEW R (US) 2014-09-25 WO disclosed
US-20130108574-A1 RADIOPAQUE, NON-BIODEGRADABLE, WATER-INSOLUBLE IODINATED BENZYL ETHERS OF POLY(VINYL ALCOHOL), PREPARATION METHOD THEREOF, INJECTABLE EMBOLIZING COMPOSITIONS CONTAINING THEREOF AND USE THEREOF MERIT MEDICAL SYSTEMS, INC. 2013-05-02 US disclosed
EP-2545085-A1 RADIOPAQUE, NON- BIODEGRADABLE, WATER - INSOLUBLE IODINATED BENZYL ETHERS OF POLY (VINYL ALCOHOL), PREPARATION METHOD THEREOF, INJECTABLE EMBOLIZING COMPOSITIONS CONTAINING THEREOF AND USE THEREOF Universite Claude Bernard Lyon 1 (UCBL) (FR) 2013-01-16 EP disclosed
WO-2011110589-A1 RADIOPAQUE, NON- BIODEGRADABLE, WATER - INSOLUBLE IODINATED BENZYL ETHERS OF POLY (VINYL ALCOHOL), PREPARATION METHOD THEREOF, INJECTABLE EMBOLIZING COMPOSITIONS CONTAINING THEREOF AND USE THEREOF UNIVERSITÉ CLAUDE BERNARD LYON 1 (UCBL) (FR) 2011-09-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11672876-B2 Imageable embolic microsphere MKI67, PCNA, VHL MEN1 103/4885KMT2A 2018/4885TDP1 1561/4885
US-11383008-B2 Surface-modified polymeric substrates grafted with a properties-imparting compound using clip chemistry CLASP1, MACF1, MICA MEN1 2423/4885KMT2A 1207/4885TDP1 1917/4885
US-20230285601-A1 NON DEGRADABLE RADIO-OPAQUE EMBOLISATION MICROSPHERE KIT, TIE1, HRH4 MEN1 1587/4885KMT2A 1595/4885TDP1 2001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.